Themis Medicare's Stock Hits 52-Week High, Outperforms Sector and Market Trends
Themis Medicare, a smallcap pharmaceutical company, has reached a new milestone as its stock price hit a 52-week high on September 20, 2024. According to MarketsMojo, the current recommendation for the stock is 'Hold', based on its strong performance and market trends. The stock has outperformed its sector by 11.42% today and is trading higher than its moving averages, indicating a positive trend. With a 68.11% increase in its stock price in the past year, Themis Medicare shows potential for growth in the pharmaceutical industry.
Themis Medicare, a smallcap pharmaceutical company, has recently reached a new milestone as its stock price touched a 52-week high on September 20, 2024. This comes as a positive development for the company, which has been performing well in the market.
According to MarketsMOJO, a leading stock analysis platform, the current recommendation for Themis Medicare's stock is 'Hold'. This is based on the company's recent performance and market trends.
In terms of price performance, Themis Medicare has outperformed its sector by 11.42% today, with the stock hitting an intraday high of Rs. 291, a 12.44% increase. The stock has also shown a trend reversal, gaining after three consecutive days of fall. It has been highly volatile today, with an intraday volatility of 5.98%.
Moreover, Themis Medicare is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in the market.
In the past year, Themis Medicare has shown a strong performance, with a 68.11% increase in its stock price, compared to the Sensex's performance of 26.27%. This further highlights the company's growth and potential in the pharmaceutical industry.
Overall, Themis Medicare's recent achievement of reaching a 52-week high and its consistent performance in the market make it a promising player in the smallcap pharmaceutical sector. Investors may want to keep an eye on this company as it continues to grow and make strides in the industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
